IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of ...

Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 104.35% over the past year to $0.94, which beat the ...

InMode (INMD) designs, develops, manufactures, and markets minimally invasive aesthetic medical products. In addition, it designs, develops, manufactures, and markets non-invasive medical aesthetic ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

InMode is a pioneer, first mover and leader in the field of minimally-invasive treatment and it generates mouth-watering returns. InMode is set to exceed investors' expectations embedded in today's ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode Ltd. (NASDAQ:INMD) is a US-based company that offers minimally invasive surgical aesthetic and medical treatments. Being one of the Best Aesthetics Stocks, its products and solutions focus on ...

In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode(NASDAQ: INMD) more than doubled as enthusiasm for all things new and ...